top of page
Profile
Join date: Nov 11, 2021
Posts (24)
Jan 17, 2025 ∙ 7 min
The $10 billion unicorn in INmune Bio: how only INMB uses the recipe behind big pharma’s recent successes with anti-amyloid antibodies
Historical failure rate of therapies targeting amyloid Alzheimer’s is characterized by aggregation of anti-amyloid antibodies and...
403
0
2
Jan 10, 2025 ∙ 6 min
The $10 billion dollar unicorn in INmune Bio: could remyelination explain the fast functional/cognitive recovery seen in patients?
Introduction I am picking up my previous work to assess the Alzheimer’s space today, with a particular focus on INmune Bio, as the...
790
0
13
Oct 21, 2022 ∙ 12 min
The $10 billion dollar unicorn in INmune Bio: on fast-progressors in AD, APOE4, TREM2 and EMACC
Summary APOE4, involved in different mechanisms in the brain including lipid homeostasis, is the strongest risk factor for Alzheimer’s...
707
0
4
Carl Kestens
Admin
More actions
bottom of page